N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide
C34H38FN3O — CID 143670831
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide
N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide (PubChem CID 143670831) has the molecular formula C34H38FN3O and a molecular weight of 523.70 g/mol. Its IUPAC name is N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide.
Molecular Properties
| Compound Name | N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide |
|---|---|
| PubChem CID | 143670831 |
| Molecular Formula | C34H38FN3O |
| Molecular Weight | 523.70 g/mol |
| Exact Mass | 523.30 |
| IUPAC Name | N-cyclopentyl-2-(2-ethylcyclopropyl)-2-[[1-(4-fluorophenyl)indazol-5-yl]-phenylmethyl]butanamide |
| SMILES | CCC1CC1C(CC)(C(=O)NC1CCCC1)C(c1ccccc1)c1ccc2c(cnn2-c2ccc(F)cc2)c1 |
| InChI | InChI=1S/C34H38FN3O/c1-3-23-21-30(23)34(4-2,33(39)37-28-12-8-9-13-28)32(24-10-6-5-7-11-24)25-14-19-31-26(20-25)22-36-38(31)29-17-15-27(35)16-18-29/h5-7,10-11,14-20,22-23,28,30,32H,3-4,8-9,12-13,21H2,1-2H3,(H,37,39) |
| InChIKey | MCCILJYNMSIFCH-UHFFFAOYSA-N |
| XLogP | 7.80 |
| TPSA | 46.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 523.70 |
| LogP ≤ 5 | 7.80 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143670831 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.